High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma
- 1 June 2004
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 805 (2) , 241-247
- https://doi.org/10.1016/j.jchromb.2004.03.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography.Journal of Chromatography B, 2003
- Highly sensitive determination of saquinavir in biological samples using liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2003
- Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatographyJournal of Chromatography B, 2002
- Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detectionJournal of Chromatography B, 2002
- Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at deliveryJournal of Chromatography B, 2002
- Interactions among Drugs for HIV and Opportunistic InfectionsNew England Journal of Medicine, 2001
- Combination Therapy with Amprenavir, Abacavir, and Efavirenz in Human Immunodeficiency Virus (HIV)-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral ActivityClinical Infectious Diseases, 2000
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- Antiretroviral Therapy for HIV InfectionJAMA, 1998